JakJanz Overcoming Rheumatism

JakJanz Overcoming Rheumatism Rheumatoid Arthritis +
Psoriatic Arthritis +
Ankylosing Spondylitis +
Ulcerative Colitis +
PcJIA

18/10/2024
17/10/2024

J A K J A N Z
JAK1 - JAK2 - JAK3
(A Broad Spectrum Approach)

ACTIVE PHARMACEUTICAL INGRIDIENT IS MHRA APPROVED.A SYMBOL OF SUPERIOR QUALITY.
25/07/2024

ACTIVE PHARMACEUTICAL INGRIDIENT IS MHRA APPROVED.
A SYMBOL OF SUPERIOR QUALITY.

23/07/2024

T A P
Treatment Access Program
Buy 1 and Get 1 Pack as Free

Awareness Alert:Patients deserve effective medications.Light + Air + Moisture exposures affect the efficacy.
23/07/2024

Awareness Alert:
Patients deserve effective medications.
Light + Air + Moisture exposures affect the efficacy.

TOFACITINIB (JAKJANZ) 5MG
23/02/2024

TOFACITINIB (JAKJANZ) 5MG

A recent study highlights Tofacitinib's, a drug used to treat rheimatoid arthritis, promising results in treating baldness. Tofacitinib monotherapy showed a 23.5% hair regrowth in eight months, maintaining with 5mg alternate-day dosage. However, efficacy diminishes for patients with over 10 years of...

SAPHO Syndrome....
08/12/2023

SAPHO Syndrome....

Uveitis....
07/12/2023

Uveitis....

Behcet's Disease....
06/12/2023

Behcet's Disease....

Lichen Planus....
04/12/2023

Lichen Planus....

Takayasu Arteritis...
28/11/2023

Takayasu Arteritis...

Address

Karachi
75850

Alerts

Be the first to know and let us send you an email when JakJanz Overcoming Rheumatism posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to JakJanz Overcoming Rheumatism:

Share